| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.67B | 23.51B | 23.59B | 22.93B | 23.98B | 22.00B |
| Gross Profit | 11.15B | 11.19B | 10.99B | 10.07B | 10.75B | 10.61B |
| EBITDA | 6.10B | 6.84B | 6.66B | 5.35B | 6.11B | 6.26B |
| Net Income | 4.18B | 4.34B | 3.99B | 3.37B | 4.20B | 4.16B |
Balance Sheet | ||||||
| Total Assets | 27.32B | 27.21B | 27.46B | 25.97B | 29.86B | 31.24B |
| Cash, Cash Equivalents and Short-Term Investments | 11.45B | 8.35B | 8.42B | 7.91B | 11.27B | 16.08B |
| Total Debt | 4.88B | 4.39B | 5.54B | 5.61B | 7.06B | 10.06B |
| Total Liabilities | 9.49B | 9.46B | 11.05B | 11.27B | 13.15B | 16.27B |
| Stockholders Equity | 17.84B | 17.75B | 16.37B | 14.65B | 16.63B | 14.90B |
Cash Flow | ||||||
| Free Cash Flow | 3.09B | 3.52B | 4.71B | 3.68B | 3.49B | 5.10B |
| Operating Cash Flow | 4.15B | 4.16B | 5.15B | 4.22B | 3.91B | 5.42B |
| Investing Cash Flow | 654.53M | -47.98M | -2.64B | -3.15B | -3.43B | -2.91B |
| Financing Cash Flow | -3.53B | -4.16B | -2.44B | -7.43B | -5.34B | -3.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$1.01B | 3.70 | 5.08% | 10.44% | -1.19% | -9.05% | |
67 Neutral | HK$55.47B | 8.37 | 24.70% | 3.26% | 2.03% | 1.43% | |
67 Neutral | HK$71.64B | 13.02 | 30.51% | 5.46% | -1.68% | 22.06% | |
67 Neutral | HK$7.68B | 17.92 | 7.42% | 1.41% | 7.29% | -33.19% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | HK$3.45B | 9.22 | 4.53% | 2.90% | 0.52% | 99.51% | |
58 Neutral | HK$7.65B | 5.21 | 6.29% | ― | 100.45% | 2.89% |